Silverarc Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Silverarc Capital Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,136,206	Closed	-$6.26M	–	107
2022 Q3	$6.26M	Buy	1,136,206 +61,327	+6%	+$340K	2.12%	19
2022 Q2	$3.92M	Buy	1,074,879 +70,480	+7%	+$333K	1.21%	28
2022 Q1	$6.08K	Buy	1,004,399 +264,795	+36%	+$1.61M	2.51%	10
2021 Q4	$6.24M	Buy	+739,604	New	+$6.46M	2.53%	14

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Silverarc Capital Management's APEN Position: Q4 2022 in Review

Silverarc Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2022, closing a stake of 1,136,206 shares — an estimated $6.26M sold.

Silverarc Capital Management first reported a position in APEN in Q4 2021 and held it in 4 quarters. The position peaked at $6.26M in Q3 2022. 81 funds tracked by Wall St. Rank hold APEN as of Q4 2022.

Silverarc Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q4 2022 after selling out during the quarter.
Silverarc Capital Management sold 1,136,206 Apollo Endosurgery, Inc. shares in Q4 2022, an estimated $6.26M.
Silverarc Capital Management first reported a position in Apollo Endosurgery, Inc. in Q4 2021 and held it in 4 quarters.
Silverarc Capital Management's Apollo Endosurgery, Inc. position peaked at $6.26M in Q3 2022.
81 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2022.

Based on Silverarc Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.